SignalXSignalX

CONMED Corp (CNMD) 8-K Current Report: March 13, 2026

Filed: March 13, 2026
Health Care
Electromedical & Electrotherapeutic Apparatus
CONMED Corp Overview

CONMED Corp (CNMD) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 5.02: Departure/Election of Directors or Officers

CONMED Corp 8-K Mar 13, 2026 Event Analysis

Item 5.02 · Departure/Election of Directors or Officers

  • • CFO role vacant — Andrew Moller named Interim Principal Financial Officer effective March 15, 2026, signaling unplanned departure of prior CFO
  • • Moller is an internal promotion from VP Corporate Controller/Principal Accounting Officer, a role he held only since April 2025
  • • Prior experience: Global Controller & CFO Asia-Pacific at Smith & Nephew (2019–2024) and Director of Internal Audit at Stanley Black & Decker
  • • No compensation change tied to interim appointment — suggests temporary, transitional role pending permanent CFO search
  • • CFO instability at a medtech company mid-fiscal year warrants monitoring; permanent hire announcement will be a key catalyst

Get deeper insights on CONMED Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.